FDA drug recalls

Formal FDA enforcement reports for prescription and over-the-counter drugs — contamination, wrong potency, mislabeling, and manufacturing failures. 341 recalls in the last 12 months, in plain English.

Recent recalls

Page 9 of 12
  • Appco Pharma prazosin capsules recalled for nitrosamine impurity

    Appco Pharma LLC is recalling prazosin hydrochloride 1mg capsules (100-count bottles) because they may contain higher-than-acceptable levels of a nitrosamine impurity. This impurity was detected during manufacturing quality checks. The recall affects specific lot numbers distributed nationwide.

    ModerateFDAApr 8, 2026Appco Pharma3 products

  • Walgreens, Good Sense and more eye drops recalled for sterility

    K.C. Pharmaceuticals is recalling eight sterile eye drop products because the company cannot confirm they are sterile. The drops were sold under store and pharmacy brands including Best Choice, Walgreens, GERI CARE, LEADER, Good Sense, Industrial Eye Relief and Rugby. No injuries have been reported.

    ModerateFDAApr 8, 2026K.C. Pharmaceuticals8 products

  • Amneal tramadol tablets recalled for impurity out of specification

    Amneal Pharmaceuticals is recalling specific lots of tramadol 50 mg tablets because they contain higher-than-allowed levels of a chemical impurity called N-nitroso-desmethyl-tramadol (NDSRI). The impurity was discovered during stability testing of tablets nearing the end of their shelf life. No injuries have been reported.

    ModerateFDAApr 8, 2026Amneal Pharmaceuticals

  • Alembic bromfenac eye drops recalled for failed impurity testing

    Alembic Pharmaceuticals is recalling specific lots of Bromfenac Ophthalmic Solution 0.07% because the medication failed purity and degradation tests during stability testing at 20 months. The affected eye drops may contain higher-than-acceptable impurity levels, which could affect safety and effectiveness.

    ModerateFDAApr 8, 2026Alembic Pharmaceuticals

  • Stop using recalled Meclizine Hydrochloride tablets

    American Health Packaging is recalling specific batches of Meclizine Hydrochloride 12.5 mg tablets because they failed to meet required tablet specifications. The affected product is Lot #1024852 with an expiration date of 9/30/2026. No injuries have been reported.

    ModerateFDAApr 1, 2026Amerisource

  • Stop using Teva Octreotide Acetate injection

    Teva Pharmaceuticals is recalling specific lots of Octreotide Acetate injectable suspension due to sterility concerns identified at the manufacturing facility. The FDA found quality system deficiencies that could affect the safety of the medication.

    ModerateFDAApr 1, 2026Teva3 products

  • Macleods levothyroxine tablets recalled for subpotency

    Macleods Pharma USA is recalling Levothyroxine Sodium Tablets USP 150 mcg because they may contain less active ingredient than labeled. This means the medication may not work as intended to treat thyroid conditions. The affected lot is 16240062A with an expiration date of March 2026.

    ModerateFDAApr 1, 2026MacLeods Pharma

  • Stop using recalled CUROSURF lung surfactant

    Chiesi USA is recalling specific lots of CUROSURF, a medication given to premature infants to help them breathe. The company cannot confirm that all vials are sterile, which means they may be contaminated. No infections have been reported so far.

    ModerateFDAApr 1, 2026Chiesi

  • Stop using Radnostix Gelatin Capsule Pack

    Radnostix Gelatin Capsule Packs used with Sodium Iodide I-131 Kit have failed quality specifications. The affected capsules may not perform as intended. Three specific lots distributed nationwide are involved.

    ModerateFDAApr 1, 2026Radnostix

  • Apotex brimonidine/timolol eye drops recalled for lack of sterility assurance

    Apotex Corp. is recalling specific lots of brimonidine tartrate/timolol maleate eye drops because the manufacturer cannot confirm the product was sterilized properly. The affected lots are VJ8599 (expires 09/30/2026) and VL1668 (expires 01/31/2027). No infections or injuries have been reported so far.

    ModerateFDAMar 25, 2026Apotex

  • Stop using Somerset Therapeutics dexamethasone injection

    Somerset Therapeutics is recalling one lot of dexamethasone sodium phosphate injection because testing found impurity levels above acceptable limits as the product approached its expiration date. The affected lot (A240421, expiring 07/31/2026) was distributed nationwide. No injuries have been reported.

    ModerateFDAMar 25, 2026Somerset Therapeutics

  • Annora Pharma pitavastatin 2 mg tablets recalled for foreign tablet

    A 1 mg Pitavastatin tablet was found mixed into a bottle labeled as containing 2 mg tablets. This occurred in one lot (A252487) distributed in Tennessee. Taking the wrong dose by mistake could affect how well your cholesterol medication works.

    ModerateFDAMar 25, 2026Annora Pharma

  • Strides Pharma children's ibuprofen recalled for foreign substance

    Strides Pharma Children's Ibuprofen Oral Suspension (100 mg per 5 mL) has been recalled because some bottles contain gel-like masses and black particles. The affected bottles are 4 FL OZ (120 mL) size with lot numbers 7261973A or 7261974A, expiring 01/31/2027. No injuries have been reported.

    ModerateFDAMar 25, 2026Strides

  • Icosapent Ethyl Capsules, 1 gram, 120 Capsules per bottle, Rx only, Manufactured by: Softgel Healthcare Pvt. Ltd., India; Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534. NDC: 70710-1592-7

    Failed Tablet/Capsule specifications: Red dots inside capsule and melted capsule caused by oxidized Icosapent ethyl, the active ingredient.

    FDAMar 18, 2026Zydus

  • Amnesteem isotretinoin capsules recalled for failed dissolution

    Mylan Pharmaceuticals is recalling specific lots of Amnesteem (isotretinoin) 40 mg capsules because they failed to meet dissolution specifications—meaning the medication may not break down and be absorbed by your body as intended. This could affect how well the medicine works. The recall affects two lots (3116110 and 3116130) with an expiration date of July 2026.

    ModerateFDAMar 11, 2026Mylan

  • MR. 7 SUPER 700000 capsules recalled for undeclared sildenafil, tadalafil

    MR. 7 SUPER 700000 capsules contain hidden prescription drugs—sildenafil and tadalafil—that are not listed on the label. These are serious medications that can interact with other drugs and cause health problems. The product was sold without FDA approval.

    SeriousFDAMar 11, 2026Stuffby Nainax

  • Mojo Max Fusion XXX recalled for undeclared sildenafil and tadalafil

    Mojo Max Fusion XXX capsules contain hidden prescription drugs—sildenafil and tadalafil—that were not listed on the label. These are potent medications that can cause serious health problems, especially if you take other drugs or have certain heart or blood pressure conditions. The FDA has not approved this product for sale.

    SeriousFDAMar 11, 2026Mohamed Hagar

  • Nomida semaglutide and tirzepatide vials recalled for sterility concerns

    New Life Pharma is recalling four sterile multi-dose vials of semaglutide and tirzepatide injection, all sold under the Nomida name, because the company cannot assure they are sterile. The recall covers 2 mg and 10 mg semaglutide vials and 10 mg and 15 mg tirzepatide vials, and the products were distributed in Ohio. No injuries have been reported.

    ModerateFDAMar 11, 2026New Life Pharma4 products

  • Do not use Radnostix Sodium Iodide I-131 solution

    Radnostix Sodium Iodide (I-131) Solution, a prescription oral therapeutic medication, is being recalled because some vials contain particulate matter due to production issues. The affected medication is in 1 ml, 2 ml, and 3 ml vials with batch number I012626R-01 and expiration date 02/09/2026. No injuries have been reported.

    ModerateFDAMar 11, 2026Radnostix

  • Silintan pills recalled for undeclared meloxicam

    SILINTAN 25 pills, sold in 25-count bottles, contain an undeclared ingredient called meloxicam, a prescription pain reliever. The FDA found this ingredient was not listed on the label and the product was not approved by the FDA. The recall affects all lots currently in use.

    SeriousFDAMar 11, 2026123Herbals

  • Five-Star Vasocaine and Maximum lidocaine recalled over expiry dates

    Kirkman is recalling three topical numbing products, distributed by Dermal Source of Portland, OR: Five-Star Vasocaine spray, Maximum Zone 1 lidocaine cream, and Maximum Zone 2 lidocaine cream. The company's stability testing does not support the expiry dates printed on these products. No injuries have been reported.

    ModerateFDAMar 11, 2026Kirkman3 products

  • Stop using Rising Pharma Temozolomide capsules

    Rising Pharmaceuticals is recalling specific bottles of Temozolomide 5mg capsules because testing found the medication didn't meet quality standards for purity and stability. The issue was discovered during routine 9-month stability testing. This affects 1,200 bottles distributed nationwide with expiration date 09/2026.

    ModerateFDAMar 11, 2026Rising Pharma

  • Major Pharmaceuticals midodrine tablets recalled for packaging defect

    Major Pharmaceuticals is recalling midodrine hydrochloride 5 mg tablets (Lot N02640, expiring 08/2027) because some blister packages are not properly sealed. Defective packaging could allow the medication to degrade or become contaminated. No injuries have been reported.

    ModerateFDAMar 11, 2026The Harvard Drug

  • Cipla USA nilotinib capsules recalled for failed appearance tests

    Cipla USA is recalling specific lots of Nilotinib 150 mg capsules because testing found the capsules did not meet appearance and description standards after six months of storage. The affected lots are 5GJ0220, 5GJ0221, and 5GJ0222, with expiration date 04/30/2027. No injuries have been reported.

    ModerateFDAMar 11, 2026Cipla2 products

  • Do not use Harbin Jixianglong semaglutide

    Harbin Jixianglong Biotech distributed semaglutide (an injectable medication for compounding) without completing required manufacturing process and bacterial endotoxin testing. This means the drug may not meet safety and purity standards. The affected lot is CP-030-20250711 with an expiration date of July 24, 2027.

    ModerateFDAMar 11, 2026Jixianglong2 products

  • First Aid Only and Med-Nap BZK wipes recalled for manufacturing deviations

    Acme United Corporation is recalling 21 antiseptic and hand sanitizing towelette and wipe products nationwide for manufacturing (CGMP) deviations, a Class II classification. The products are sold under names including First Aid Only, Med-Nap, Dukal, Dynarex, Piedmont Sanitizing, Max Packaging, Savannah, Medi-First, Wipes Plus, WP WipesPlus, Green Guard, and Children's Healthcare of Atlanta, among others. No injuries have been reported.

    ModerateFDAMar 11, 2026Acme21 products

  • Teva metoprolol succinate tablets recalled for dissolution failure

    Teva is recalling four strengths of metoprolol succinate extended-release tablets (25 mg, 50 mg, 100 mg and 200 mg), sold in 100- and 1,000-tablet bottles. The tablets did not meet the required dissolution specification, which means they may not release the medicine at the expected rate. No injuries have been reported.

    ModerateFDAMar 11, 2026Teva4 products

  • Vista, Bio Glo and CHNaO eye products recalled for sterility

    Wizcure Pharma is recalling seven eye products sold nationwide: Vista dry eye drops (Vista Tears, Vista Gel, Vista Meibo Tears and Vista Gonio), Bio Glo and BioGlo fluorescein diagnostic test strips, and CHNaO fluorescein test strips. The FDA says the products were not made under current good manufacturing practices, so the company cannot assure they are sterile. No injuries have been reported.

    ModerateFDAMar 4, 2026Wizcure Pharma7 products

  • Agebox iKids-Growth supplements recalled for undeclared ibutamoren

    The FDA says Agebox iKids-Growth capsules contain ibutamoren, an ingredient that is not listed on the label and is not approved for use in these products. The recall covers two products, both sold as 60-count bottles of Agebox iKids-Growth capsules: a Day Formula and a Night Formula. No injuries have been reported.

    ModerateFDAMar 4, 2026Agebox2 products

  • Check Slate Run Eptifibatide Injection labeling

    Slate Run Pharmaceuticals is recalling Eptifibatide Injection 75 mg/100 mL vials because the carton label says "weight-adjusted bolus dosing" when it should say "weight-adjusted infusion." This labeling error could lead to incorrect administration of the medication. No injuries have been reported.

    ModerateFDAMar 4, 2026Slate Run Pharmaceuticals

Explore other recall topics